Abstract
Objective
To define predictors for prolonged ICU stay in order to improve patient outcome and reduce costs.
Patients and methods
Prospective data on 10,759 patients undergoing coronary artery bypass grafting with and without use of cardiopulmonary bypass (coronary artery bypass grafting, CABG; n =8,917; off-pump coronary artery bypass grafting, OPCAB; n =765; minimally invasive direct coronary artery bypass grafting, MIDCAB; n =1,077) between April 1996 and August 2001 were subjected to univariate and, consecutively, to multivariate logistic regression analysis. Prolonged ICU stay was defined as intensive care treatment for three postoperative days and longer.
Measurements and results
Mean duration of ICU stay was 3.8±6.9 days; overall prevalence of prolonged ICU stay was 37.1%. The hospital mortality was 3.5% (ICU ≥3 days: 5.9%; ICU <3 days: 2.0%). Out of 39 selected pre- and intraoperative patient- and treatment-related variables, by univariate analysis, 32 variables having a high association with prolonged ICU stay were identified. Using a stepwise logistic regression model, 20 variables were shown to be independent predictors for prolonged ICU stay. Both OPCAB and MIDCAB surgery were identified as having a significantly lower association with prolonged ICU stay.
Conclusion
As prolonged ICU stay is associated with poor patient outcome and increased costs it is of utmost importance to identify patients at a high risk for prolonged ICU stay. More frequent off-pump CABG may optimize patient outcome.
Similar content being viewed by others
References
Ryan TA, Rady MY, Bashour A, Leventhal M, Lytle B, Starr NJ (1997) Predictors of outcome in cardiac surgical patients with prolonged intensive care stay. Chest 112:1035–1042
Tuman KJ, McCarthy RJ, March RJ, Najafi H, Ivankovich AD (1992) Morbidity and duration of ICU stay after cardiac surgery. A model for preoperative risk assessment. Chest 102:36–44
Rosenberg AL, Watts C (2000) Patients readmitted to ICUs. A systemic review of risk factors and outcomes. Chest 118:492–502
Warner CD, Weintraub WS, Craver JM, Jones EL, Gott JP, Guyton RA (1997) Effect of cardiac surgery patient characteristics on patient outcomes from 1981 through 1995. Circulation 96:1575–1579
Kalmár P, Irrgang E (2000) Cardiac surgery in Germany during 2000. A report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 48:33–38
Petros AJ, Marshall JC, van Saene HKF (1995) Should morbidity replace mortality as an end-point for clinical trials in intensive care? Lancet 345:369–371
Hammermeister M, Burchfield C, Johnson R, Grover FL (1990) Identification of patients at greatest risk for developing major complications after cardiac surgery. Circulation 82[Suppl]):380–389
Gummert JF, Kluge M, Reissmann EM, Bung J, Mohr FW (1998) Einführung eines komplexen medizinischen Dokumentationssystems am Herzzentrum Leipzig. In: Krian A, Scheld HH (ed) Dokumentationsverfahren in der Herzchirurgie III. Steinkopff, Darmstadt, pp 99–103
Rosner BA (1995) Fundamentals of biostatistics, 4th edn. Duxbury-Press, Belmont, Calif., USA
Tu JV, Jaglal SB, Naylor CD, and the Steering Committee of the Provincial Adult Cardiac Care Network of Ontario (1995) Multicenter validation of a risk index for mortality, intensive care unit stay and overall hospital length of stay after cardiac surgery. Circulation 91:677–684
Lynn GM, Stefanko K, Reed JF III, Gee W, Nicholas G (1992) Risk factors for stroke after coronary artery bypass. J Thorac Cardiovasc Surg 104:1518–1523
Newman MF, Wolman R, Kanchuger M, Marschall K, Mora-Mangano C, Roach G, Smith LR, Aggarwal A, Nussmeier N, Herskowitz A, Mangano DT (1996) Multicenter preoperativestroke risk index for patients undergoing coronary artery bypass graft surgery. Circulation 94[Suppl 2]:74–80
Horneffer PJ, Gardner TJ, Manolio TA, Hoff SJ, Rykiel MF, Pearson PA, Gott VL, Baumgartner WA, Borkon AM, Watkins L (1987) The effects of age on outcome after coronary bypass surgery. Circulation 76:6–12
Avery II GJ, Ley SJ, Hill D, Hershon JJ, Dick SE (2001) Cardiac surgery in the octogenerian: evaluation of risk, cost, and outcome. Ann Thorac Surg 71:591–596
Roach GW, Kanchuger M, Mora Mangano C, Newman M, Nussmeier N, Wolman R, Aggarwal A, Marschall K, Graham SH, Ley C (1996) Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of perioperative ischemia research group and the ischemia research and education foundation investigators. N Engl J Med 335:1857–1863
Stamou SC, Hill PC, Dangas G, Pfister AJ, Boyce SW, Dullum MK, Bafi AS, Corso PJ (2001) Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 32:1508–1513
Morricone L, Ranucci M, Denti S, Cazzaniga A, Isgro G, Enrini R, Caviezel F (1999) Diabetes and complications after cardiac surgery: comparison with a non-diabetic population. Acta Diabetol 36:77–84
Rorich MB, Furlan AJ (1990) Risk at cardiac surgery in patients with prior stroke. Neurology 40:835–837
Shaw PJ, Bates D, Cartlidge NEF, French JM, Heaviside D, Julian DG, Shaw DA (1989) An analysis of factors predisposing to neurological injury in patients undergoing coronary bypass operations. Q J Med 72:633–646
Hammon JW Jr, Stump DA, Kon ND, Cordell AR, Hudspeth AS, Oaks TE, Brooker RF, Rogers AT, Hilbawi R, Coker LH, Troost BT (1997) Risk factors and solutions for the development of neurobehavioral changes after coronary artery bypass grafting. Ann Thorac Surg 63:1613–1618
Clark RE, Brillman J, Davis DA, Lovell MR, Price TR, Magovern GJ (1995) Microemboli during coronary artery bypass grafting. Genesis and effect on outcome. J Thorac CardiovascSurg 109:249–257
Kurki TSO, Kataja M (1996) Preoperative prediction of postoperative morbidity in coronary artery bypass grafting. Ann Thorac Surg 61:1740–1745
Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranadi L (1992) Stratification of morbidity and mortality outcome by preoperative risk factors in coroanry artery bypass patients. JAMA 267:2344–2348
Anderson RJ, O' Brian M, MaWhinney S, Villa Nueva CB, Moritz TE, Sethi GK, Henderson WG, Hammermeister KE, Grover FL, Shroyer AL (1999) Renal failure predisposes patients to adverse outcome after coronary bypass surgery. Kidney Int 55:1057–1062
Hannan EL, Kilburn H, O'Donnell J, Lukacik G, Shields EP (1990) Adult open heart surgery in New York State. An analysis of risk factors and hospital mortality rates. JAMA 264:2768–2774
Murkin JM, Boyd WD, Ganapathy S, Adams SJ, Peterson RC (1999) Beating heart surgery: why expect less central nervous system morbidity? Ann Thorac Surg 68:1498–1501
Kshettry VE, Flavin TF, Emery RW, Nicoloff DM (2000) Does multi-vessel off-pump coronary artery bypass (OPCABG) reduce postoperative morbidity? Ann Thorac Surg 69:1725–1730
Mack MJ, Osborne JA, Shennib H (1998) Arterial graft patency in coronary artery bypass grafting: what do we really know? Ann Thorac Surg 66:1055–1059
Bull DA, Neumayer LA, Stringham JC, Meldrum P, Affleck DG, Karwande SV (2001) Coronary artery bypass grafting with cardiopulmonary bypass versus off-pump cardiopulmonary bypass grafting: does eliminating the pump reduce morbidity and cost? Ann Thorac Surg 71:170–175
Plomondon ME, Cleveland JC, Ludwig ST, Grunwald GK, Kiefe CI, Grover FL, Shroyer AL (2001) Off-pump coronary artery bypass is associated with improved risk-adjusted outcomes. Ann Thorac Surg 72:114–119
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
The following table shows peroperative variables analyzed by univariate analysis (factors that had a statistically significant association with prolonged ICU-stay are printed in bold)
Patients with ICU−stay ≥3 days (n =3,988) | Patients with ICU−stay <3 days (n =6,771) | ||
---|---|---|---|
Preoperative variables | Prevalence % (n) | P−value | |
Age | |||
Age <60 years | 18.3% (730) | 29.1% (1,973) | <0.0001 |
Age ≥70 and <80 years | 37.2% (1,483) | 28.4% (1,926) | <0.0001 |
Age ≥80 years | 4.3% (171) | 2.4% (161) | <0.0001 |
History of syncope | 8.4% (336) | 7.3% (494) | 0.033 |
History of embolism | 3.5% (138) | 2.2% (148) | <0.0001 |
History of cardiogenic shock | 11.1% (442) | 5.2% (353) | <0.0001 |
Diabetes mellitus (glucose intolerance treated with diet, oral hypoglycemics or insulin) | 41.2% (1,645) | 33.1% (2,238) | <0.0001 |
Arterial hypertension (patient taking antihypertensive medication preoperatively) | 75.8% (3,021) | 72.3% (4,898) | <0.0001 |
History of renal disease (history of renal failure or pathological elevated serum creatinine treated medically without hemofiltration and/or dialysis) | 6.4% (256) | 2.3% (159) | <0.0001 |
Dialysis dependent renal insufficiency | 1.1% (42) | 0.3% (19) | <0.0001 |
Preoperative infection (infectious disease including endocarditis) | 1.5% (59) | 0.6% (42) | <0.0001 |
History of cerebrovascular disease (including stroke, TIA, and PRIND) | 4.7% (186) | 2.6% (178) | <0.0001 |
NYHA ≥3 | 81.8% (3,263) | 76.4% (5,175) | <0.0001 |
LVEF ≤30% (assessed by angiography or 2D echocardiography) | 11.1% (441) | 6.1% (413) | <0.0001 |
History of peripheral vascular disease | 26.2% (1,046) | 17.2% (1,164) | <0.0001 |
Atrial fibrillation (history of preoperative atrial fibrillation) | 5.9% (235) | 3.0% (202) | <0.0001 |
Urgent operation | 27.5% (1,097) | 16.4% (1,100) | <0.0001 |
Emergency surgery (emergent surgery due to complications during coronary angiography and/or PTCA) | 1.1% (42) | 0.6% (39) | 0.008 |
History of pulmonary disease (chronic pathologic pulmonary function test) | 8.0% (320) | 4.8% (325) | <0.0001 |
Prior myocardial infarction | 58.5% (2,331) | 51.4% (3,479) | <0.0001 |
CCS ≥3 | 37.8% (1,509) | 35.9% (2,435) | 0.05 |
Sex (male) | 76.2% (3,039) | 77.5% (5,250) | 0.117 |
Hyperlipidemia | 52.7% (2,100) | 54.3% (3,679) | 0.155 |
Prior cardiac surgery | 4.4% (174) | 3.7% (252) | 0.102 |
Prior CABG | 3.8% (150) | 3.1% (213) | 0.097 |
Prior aortic valve surgery | 0.2% (9) | 0.4% (26) | 0.219 |
Prior mitral valve surgery | 0.1% (6) | 0.2% (16) | 0.386 |
Intraoperative variables | |||
Duration of surgery ≥3 h | 24.1% (961) | 16.4% (1,113) | <0.0001 |
Total CPB time ≥2 h | 10.9% (435) | 4.3% (293) | <0.0001 |
Ischemic time ≥1 h | 11.6% (462) | 8.9% (607) | <0.0001 |
Intraoperative hemofiltration | 9.2% (367) | 4.7% (321) | <0.0001 |
Intraoperative hypothermia ≤32 °C | 29.2% (1,166) | 21.3% (1,439) | <0.0001 |
Intraoperative RBC transfusion ≥1,000 ml | 2.9% (115) | 1.0% (67) | <0.0001 |
Intraoperative low cardiac output | 3.9% (154) | 1.1% (75) | <0.0001 |
Intraoperative IABP−support | 4.2% (168) | 1.2% (78) | <0.0001 |
Intraoperative assist device (ECMO, Berlin heart) | 1.4% (54) | 0.4% (24) | <0.0001 |
Intraoperative need for pacemaker stimulation | 19.5% (776) | 11.3% (766) | <0.0001 |
Use of cardioplegia | 76.3% (3,043) | 69.6% (4,711) | <0.0001 |
Beating heart surgery | 10.4% (415) | 21.1% (1,427) | <0.0001 |
OPCAB | 4.9% (194) | 8.0% (544) | <0.0001 |
MIDCAB | 5.3% (210) | 12.8% (867) | <0.0001 |
Coronary bypass grafts ≥2 | 82.5% (3,290) | 75.7% (5,127) | <0.0001 |
Intraoperative blood loss ≥500 ml | 0.7% (26) | 0.4% (26) | 0.061 |
CABG coronary artery bypass grafting, OPCAB off-pump coronary artery bypass grafting, MIDCAB minimally invasive direct coronary artery bypass grafting, RBC red blood cells, LVEF left ventricular ejection fraction, PTCA percutaneous transluminal coronary angioplasty, CPB cardiopulmonary bypass, IABP intra-aortic ballon pump, ECMO extracorporal membrane oxygenation
Rights and permissions
About this article
Cite this article
Bucerius, J., Gummert, J.F., Walther, T. et al. Predictors of prolonged ICU stay after on-pump versus off-pump coronary artery bypass grafting. Intensive Care Med 30, 88–95 (2004). https://doi.org/10.1007/s00134-003-1950-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-003-1950-5